Presenting author

Andrew Czysz

1 presentation

• T89. ML-007C-MA, a novel investigational M1/M4 muscarinic agonist in phase 2 development for the treatment of schizophrenia and Alzheimer’s disease psychosis

  2026 ASCP Annual Meeting